PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
Translating Science. Transforming Lives.
View Our Pipeline
Careers at PTC
PTC STRIVE Awards Program
Phase 2 Data from Spinal Muscular Atrophy Program Presented at the 20th International Annual Congress of the World Muscle Society
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PTC Therapeutics Submits European Application For Translarna™ for Cystic Fibrosis
View all latest news